404 publication(s) :

Remarque : Seuls les 15 premiers auteurs sont affichés.

Articles avec comité de lecture de revues internationales

1 - 
The multifaceted lifestyle of enterococci: genetic diversity, ecology and risks for public health
V. Cattoir
Current Opinion in Microbiology, 2022, 65, 73-80.
DOI : https://doi.org/10.1016/j.mib.2021.10.013
 Reprint request: Subject to availability
2 - 
Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study
L. Armange, F. Bénézit, L. Picard, C. Pronier, S. Guillot, P.-A. Lentz, F. Carré, P. Tattevin, M. Revest
European Journal of Clinical Microbiology and Infectious Diseases, 2021, 1-5.
DOI : https://doi.org/10.1007/s10096-021-04261-y
Pubmed : 33893570
 Reprint request: Subject to availability
3 - 
A small regulatory RNA alters Staphylococcus aureus virulence by titrating RNAIII activity
K. B. Le Huyen, C. D. Gonzalez, G. Pascreau, V. Bordeau, V. Cattoir, W. Liu, P. Bouloc, B. Felden, S. Chabelskaya
Nucleic Acids Research, 2021, 49, 10644-10656.
DOI : https://doi.org/10.1093/nar/gkab782
Pubmed : 34554192
 Reprint request: Subject to availability
4 - 
Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study
T. Bettuzzi, A. Jourdes, O. Robineau, I. Alcaraz, V. Manda, J. Molina, M. Mehlen, C. Cazanave, P. Tattevin, S. Mensi, B. Terrier, A. Régent, J. Ghosn, C. Charlier, G. Martin-Blondel et al.
The Lancet Infectious Diseases, 2021, 21, 1441-1447.
DOI : https://doi.org/10.1016/S1473-3099(20)30857-4
Pubmed : 34051142
 Reprint request: Subject to availability
5 - 
Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
A. Bleibtreu, L. Dortet, R. Bonnin, B. Wyplosz, S.-C. Sacleux, L. Mihaila, H. Dupont, H. Junot, V. Bunel, N. Grall, K. Razazi, C. Duran, P. Tattevin, A. Dinh
Microorganisms, 2021, 9, 282.
DOI : https://doi.org/10.3390/microorganisms9020282
Pubmed : 33573148
Fichier PDF
 Reprint request: Subject to availability
6 - 
Partial oral antibiotic treatment for bacterial brain abscess: an open-label randomized non-inferiority trial (ORAL)
J. Bodilsen, M. C. Brouwer, D. van de Beek, P. Tattevin, S. Tong, P. Naucler, H. Nielsen
Trials, 2021, 22, 796.
DOI : https://doi.org/10.1186/s13063-021-05783-8
Pubmed : 34772441
Fichier PDF
 Reprint request: Subject to availability
7 - 
Treatment of community-acquired bacterial brain abscess: a survey among infectious diseases specialists in France, Sweden, Australia, and Denmark
J. Bodilsen, P. Tattevin, S. Tong, P. Naucler, H. Nielsen
European Journal of Clinical Microbiology and Infectious Diseases, 2021, 40, 255-260.
DOI : https://doi.org/10.1007/s10096-020-04032-1
Pubmed : 32880024
 Reprint request: Subject to availability
8 - 
Rapid diagnostic tests for infectious diseases in the emergency department
D. Bouzid, M.-C. Zanella, S. Kerneis, B. Visseaux, L. May, J. Schrenzel, V. Cattoir
Clinical Microbiology and Infection, 2021, 27, 182-191.
DOI : https://doi.org/10.1016/j.cmi.2020.02.024
Pubmed : 32120036
Fichier PDF
 Reprint request: Subject to availability
9 - 
Bacterial gut dysbiosis is associated with Crohn’s disease symptoms but not with elevated fecal calprotectin
S. Buffet-Bataillon, C. Landreau, L. Siproudhis, V. Cattoir, G. Bouguen
Clinics and Research in Hepatology and Gastroenterology, 2021, 45, 101669.
DOI : https://doi.org/10.1016/j.clinre.2021.101669
Pubmed : 33744412
Fichier PDF
 Reprint request: Subject to availability
10 - 
Impacts of the Type I Toxin-Antitoxin System, SprG1/SprF1, on Staphylococcus aureus Gene Expression
K. Chlebicka, E. Bonar, P. Suder, E. Ostyn, B. Felden, B. Wladyka, M.-L. Pinel-Marie
Genes, 2021, 12, 770.
DOI : https://doi.org/10.3390/genes12050770
Pubmed : 34070083
Fichier PDF
 Reprint request: Subject to availability


Exporter les données affichées en CSV Exporter les données affichées en RTF